137 related articles for article (PubMed ID: 9635681)
1. Allelic loss on chromosome 22q in epithelioid sarcomas.
Quezado MM; Middleton LP; Bryant B; Lane K; Weiss SW; Merino MJ
Hum Pathol; 1998 Jun; 29(6):604-8. PubMed ID: 9635681
[TBL] [Abstract][Full Text] [Related]
2. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
3. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms.
Sirgi KE; Wick MR; Swanson PE
Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485
[TBL] [Abstract][Full Text] [Related]
4. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases.
Lasota J; Wozniak A; Kopczynski J; Dansonka-Mieszkowska A; Wasag B; Mitsuhashi T; Sarlomo-Rikala M; Lee JR; Schneider-Stock R; Stachura J; Limon J; Miettinen M
Lab Invest; 2005 Feb; 85(2):237-47. PubMed ID: 15580284
[TBL] [Abstract][Full Text] [Related]
7. From morphological to molecular diagnosis of soft tissue tumors.
Miettinen M
Adv Exp Med Biol; 2006; 587():99-113. PubMed ID: 17163160
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors.
Pylkkänen L; Sarlomo-Rikala M; Wessman M; Hämäläinen E; Sainio M; Husgafvel-Pursiainen K; Carpén O
Hum Pathol; 2003 Sep; 34(9):872-9. PubMed ID: 14562282
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations in pulmonary epithelioid hemangioendothelioma and epithelioid angiosarcoma.
Cao Y; Zou SM; Zhang KT; Lu N; Liu Y; Feng L; Wen P; Han NJ; Lin DM
Histol Histopathol; 2011 Apr; 26(4):491-6. PubMed ID: 21360442
[TBL] [Abstract][Full Text] [Related]
10. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
11. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
12. Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.
Liau JY; Tsai JH; Yang CY; Lee JC; Liang CW; Hsu HH; Jeng YM
Hum Pathol; 2015 Sep; 46(9):1360-6. PubMed ID: 26190196
[TBL] [Abstract][Full Text] [Related]
13. Epithelioid sarcoma.
Armah HB; Parwani AV
Arch Pathol Lab Med; 2009 May; 133(5):814-9. PubMed ID: 19415960
[TBL] [Abstract][Full Text] [Related]
14. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U
Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene.
Watkins D; Ruttledge MH; Sarrazin J; Rangaratnam S; Poisson M; Delattre JY; Rouleau GA
Cancer Genet Cytogenet; 1996 Nov; 92(1):73-8. PubMed ID: 8956876
[TBL] [Abstract][Full Text] [Related]
17. Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma.
Mendlick MR; Nelson M; Pickering D; Johansson SL; Seemayer TA; Neff JR; Vergara G; Rosenthal H; Bridge JA
Am J Surg Pathol; 2001 May; 25(5):684-7. PubMed ID: 11342784
[TBL] [Abstract][Full Text] [Related]
18. A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications.
Wild A; Langer P; Ramaswamy A; Chaloupka B; Bartsch DK
J Clin Endocrinol Metab; 2001 Dec; 86(12):5782-7. PubMed ID: 11739439
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST).
Jhanwar SC; Chen Q; Li FP; Brennan MF; Woodruff JM
Cancer Genet Cytogenet; 1994 Dec; 78(2):138-44. PubMed ID: 7828144
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
